Zheng Zhang mostly deals with Coronavirus, Immunology, Internal medicine, Gastroenterology and Antibody. His Coronavirus study frequently intersects with other fields, such as Middle East respiratory syndrome coronavirus. In general Immunology study, his work on CD8, Myeloid, Proinflammatory cytokine and Immune system often relates to the realm of Leukocyte L1 Antigen Complex, thereby connecting several areas of interest.
Many of his studies on Internal medicine apply to Throat as well. Many of his studies on Gastroenterology involve topics that are commonly interrelated, such as Pneumonia. Zheng Zhang regularly ties together related areas like Virology in his Antibody studies.
His primary scientific interests are in Immunology, Internal medicine, Virus, Immune system and Virology. In most of his Immunology studies, his work intersects topics such as Cytotoxic T cell. His Internal medicine study frequently links to related topics such as Gastroenterology.
His Virus research is multidisciplinary, relying on both RNA, Receptor, Computational biology and Human virome. His Immune system study combines topics in areas such as Inflammation and Peripheral blood mononuclear cell. While the research belongs to areas of Virology, he spends his time largely on the problem of Antibody, intersecting his research to questions surrounding Antigen.
His primary areas of investigation include Severe acute respiratory syndrome coronavirus 2, Virus, Virology, Immunology and Antibody. His Virus research integrates issues from RNA, Gastroenterology, Receptor, Human virome and Computational biology. His work in the fields of Immunology, such as Immune system, Pathogenesis and Cytokine, intersects with other areas such as Cytokine storm.
His study on Monoclonal antibody, Serology and Antibody response is often connected to Coronavirus as part of broader study in Antibody. His study in Serology is interdisciplinary in nature, drawing from both Titer and Seroconversion. He has researched Coronavirus in several fields, including Middle East respiratory syndrome coronavirus and Lopinavir.
Immunology, Coronavirus, Virus, Internal medicine and Severe acute respiratory syndrome coronavirus 2 are his primary areas of study. His Immunology study combines topics from a wide range of disciplines, such as Bronchoalveolar lavage and Disease. His Coronavirus research spans across into subjects like Antibody and Receptor.
His work is dedicated to discovering how Virus, RNA are connected with Hepatitis C virus, Antibody response, Coinfection and Hepatitis B virus and other disciplines. Zheng Zhang focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Gastroenterology and, in certain cases, Interquartile range and Respiratory disease. His Pathogenesis study also includes fields such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.
Juanjuan Zhao;Quan Yuan;Haiyan Wang;Wei Liu.
Clinical Infectious Diseases (2020)
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China.
Aiping Wu;Yousong Peng;Baoying Huang;Xiao Ding.
Cell Host & Microbe (2020)
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.
Mingfeng Liao;Yang Liu;Jing Yuan;Yanling Wen.
Nature Medicine (2020)
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.
Yingxia Liu;Yang Yang;Cong Zhang;Cong Zhang;Fengming Huang.
Science China-life Sciences (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Chenguang Shen;Zhaoqin Wang;Fang Zhao;Yang Yang.
JAMA (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection.
Bin Ju;Qi Zhang;Jiwan Ge;Ruoke Wang.
Nature (2020)
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study.
Qingxian Cai;Minghui Yang;Dongjing Liu;Jun Chen.
Engineering (2020)
The global burden of liver disease: The major impact of China
Fu‐Sheng Wang;Jian‐Gao Fan;Zheng Zhang;Bin Gao.
Hepatology (2014)
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
Junliang Fu;Dongping Xu;Zhenwen Liu;Ming Shi.
Gastroenterology (2007)
Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses.
Furong Qi;Shen Qian;Shuye Zhang;Zheng Zhang.
Biochemical and Biophysical Research Communications (2020)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Chinese PLA General Hospital
University of Electronic Science and Technology of China
Tsinghua University
Humanity and Health Medical Group
National Institutes of Health
University of North Carolina at Chapel Hill
Tsinghua University
University of Michigan–Ann Arbor
Weizmann Institute of Science
Sun Yat-sen University
Copenhagen Business School
Iran University of Science and Technology
Technical University of Munich
Nagoya University
Texas A&M University
Uppsala University
Centers for Disease Control and Prevention
Samsung Medical Center
University of Tübingen
Université Paris Cité
University of Gothenburg
Cornell University
NewYork–Presbyterian Hospital
University College London
Cedars-Sinai Medical Center
Shelter Insurance